531541 — KOBO Biotech Share Price
Last trade - 00:00- IN₹92.92m
- IN₹1.48bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 12.09 | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Kobo Biotech Limited is an India-based company. The Company's business segment is manufacturing active pharmaceutical ingredients (APIs)/bulk drugs. The Company has no operational activities being carried out at its Solapur site, India.
Directors
- Ajit Kamath NEC (45)
- Jignesh Patel CCO
- Zeenat Pathan DRC
- Komal Tibrewal DRC
- Rajendra Kaimal NED (41)
- Abhishek Buddhadev IND (26)
- Urja Shah IND
- Sunil Pitroda NID (55)
- Last Annual
- March 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- August 3rd, 1993
- Public Since
- January 8th, 1996
- No. of Employees
- 484
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 23,825,000
- Address
- 6-3-865, 1st Floor, Madhupala Towers, MUMBAI, 400072
- Web
- http://avonlifesciences.com/
- Phone
- +91 2242871210
- Auditors
- AN Shah & Associates
Upcoming Events for 531541
Similar to 531541
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
Ambalal Sarabhai Enterprises
Bombay Stock Exchange
FAQ
As of Today at 19:12 UTC, shares in KOBO Biotech are trading at IN₹3.90. This share price information is delayed by 15 minutes.
Shares in KOBO Biotech last closed at IN₹3.90 and the price had moved by +48.85% over the past 365 days. In terms of relative price strength the KOBO Biotech share price has outperformed the S&P BSE 100 Index by +15.45% over the past year.
There is no consensus recommendation for this security.
KOBO Biotech does not currently pay a dividend.
KOBO Biotech does not currently pay a dividend.
KOBO Biotech does not currently pay a dividend.
To buy shares in KOBO Biotech you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹3.90, shares in KOBO Biotech had a market capitalisation of IN₹92.92m.
Here are the trading details for KOBO Biotech:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 531541
Based on an overall assessment of its quality, value and momentum KOBO Biotech is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like KOBO Biotech. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +25.29%.
As of the last closing price of IN₹3.90, shares in KOBO Biotech were trading +15.83% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The KOBO Biotech PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹3.90.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
KOBO Biotech's management team is headed by:
- Ajit Kamath - NEC
- Jignesh Patel - CCO
- Zeenat Pathan - DRC
- Komal Tibrewal - DRC
- Rajendra Kaimal - NED
- Abhishek Buddhadev - IND
- Urja Shah - IND
- Sunil Pitroda - NID